Janssen

Charles River Laboratories

Follow

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guides us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. Today, we operate more than 150 facilities in 21 countries and have worked on over 80% of the FDA-approved drugs over the last five years and 85% of FDA-approved drugs in 2023 alone. As a partner of choice for our clients’ nonclinical drug research and development needs, we differentiate ourselves through our broad portfolio, scientific expertise, global scale, and excellent service.

Kite Pharma

Follow

Kite, a Gilead Company, is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer. This mission is at the heart of everything we do, from early research to product development. For the past three decades, members of our team have been at the forefront of cancer immunotherapy. Today, we are a leader in engineered T cell therapy, changing the paradigm of cancer treatment with what is potentially the biggest breakthrough since the introduction of combination chemotherapy more than 60 years ago. With an unrelenting drive and a singular focus on cell therapy, our team is executing on our strategy to bring life-saving therapies to patients. In all areas of the company, we are looking for the very best people who share our deep passion to cure cancer. We realize that our ambitious goals can only be achieved if every employee is fully committed to our mission and embraces our entrepreneurial spirit. If this describes you, please contact us.

Neurocrine Biosciences

Follow

Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in patients with Prader-Willi syndrome, endometriosis* and uterine fibroids,* as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, X, Facebook and YouTube. (*in collaboration with AbbVie)

IPSEN

Follow

At Ipsen, all our teams are focused to work on prolonging patients’ lives, improving health outcomes and creating a real impact for patients and society. ​ With a global footprint and over 90 years of experience, our vision is to lead in the development of transformative medicines for highly specific and under-served diseases in oncology, rare disease and neuroscience. Every day, we empower our +5000 colleagues to join us in this journey, by creating opportunities to learn and grow while also having fun at work and giving back to the community. We also strive to provide an inclusive workplace where everyone can be their true-selves. We were able to achieve 55% representation of women on our Global Leadership Team in 2025, up from 43% in 2021. 61% of our permanent workforce and 55% of our managers are women. 

Sanofi

Follow

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and creating compelling growth. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives. Whether it’s using AI to shorten drug-discovery times or building trust in healthcare, you could be helping our teams make life better for patients, partners, and communities. This is where you grow your career. We open the door for you to explore new opportunities, push your limits, and connect with people who are driven by a shared purpose.

Lundbeck

Follow

Today, millions of people all over the world live with brain diseases. Every day, at Lundbeck we strive to further understand these diseases, develop the best therapies to treat them and make a difference to people living with them. We are one of the only pharmaceutical companies in the world focusing exclusively on brain diseases, and we’re set apart by our specialization. Our purpose is clear: We are committed to advancing brain health and transforming lives Driven by research… For more than 70 years, we’ve been pushing the boundaries of neuroscience. By combining the logic of science with our passion for making a difference to patients, we’ve pioneered some of the most important and commonly used therapies within antipsychotics and antidepressants. We work closely with patients, healthcare professionals and the neuroscience community to uncover causes and to find new treatments that can bring back quality of life to people living with brain diseases. …raising our voice… When every other organ in our body gets sick, we find compassion and care. When our brain suffers, the world typically turns away. As a global specialist, we owe it to those who live with brain diseases to fight stigma and promote better treatment. That’s why we work to improve understanding and parity of care across communities and societies – so we can empower people and rebuild hope. …giving profit a purpose… The Lundbeck Foundation is the majority owner of Lundbeck. Foundation ownership allows us to stay focused on our areas of specialization. It also means that we are in a position to give back. With donations of approximately DKK 500 million a year to biomedical research, the foundation supports the progress of health science. …and working with one aim. Today, we’re over 5,000 people in +20 countries. We build on our Danish heritage, fostering a culture of collaboration and responsibility. Whether we work in labs or in the field, we all have the same aim: to develop innovative treatments that improve the lives of people living with brain diseases.